An appeals court has upheld a ruling which bars use of the RestQ trade mark on sleep products sold by Martin & Pleasance because of a ādisturbingā number of similarities with the marketing and appearance of an established competitorās Rescue natural sleep aid product.
The companies behind the top selling Abilify medication have lost their latest bid for documents from the Commonwealth in a multimillion dollar dispute over the delayed listing of generic versions of their drug, with a judge saying the material could be only “of the most marginal relevance”.
Indonesia’s PT Garuda has withdrawn a challenge to a $19 million penalty imposed for its part in a global airline cartel, but the airline has reached an agreement with the ACCC to pay the fine in instalments.
A judge has ordered ASIC to provide more detail in its case accusing personal lender ClearLoans of contravening the hardship provisions of the credit laws, in the regulator’s first case related to the COVID-19 pandemic.
Thousands of Indonesian seaweed farmers have won a class action against PTTEP Australasia over one of Australia’s largest oil spills, with a judge finding the oil exploration company breached its duty of care to the farmers and damaged their livelihoods.
Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.
The Full Federal Court has upheld an appeal by In-N-Out Burgers against Sydney-based Hashtag Burgers, finding that its two sole directors were also liable for trademark infringement and passing off in owning and operating their ‘DOWN-N-OUT’ burger restaurants.
Casino and mobile game giant Aristocrat Leisure has reached a settlement in its lawsuit against rival Ainsworth Game Technology that alleged a former employee stole trade secrets related to a lucrative slot machine.
A judge has vacated a seven-week trial in proceedings brought by ASIC against two former Rio Tinto executives to March or April 2022, after they requested a “lengthy delay” to ensure a COVID-19 vaccine would be available before they travel to Australia for trial.
A former Rio Tinto executive living in the US who wants to appear in person at an upcoming trial in a case brought by ASIC says the hearing should be moved to next year when a COVID-19 vaccine will likely become available and he could travel to Australia to “mount a vital defence”.